Algoritmi | User | Joana Bicker
Joana Bicker
Joana Bicker
Personal Email
joana.bicker@gmail.comOrcid
0000-0001-7500-1671Researcher ID
FCT Public Key
Ciência ID
1110-A1AB-626FGoogle Scholar
About Me
Joana Bicker (JB) is an Assistant Professor at the Faculty of Pharmacy of the University of Coimbra (FFUC), integrated researcher at Coimbra Institute for Biomedical Imaging and Translational Research (CIBIT) and a European Certified Pharmacologist (EuCP). She was also PI of project EpiMod (2022.03133.PTDC). She concluded a MSc in Pharmaceutical Sciences (2011) and a PhD in Pharmacology and Pharmacotherapy (2018) at FFUC. JB was selected as researcher in project 4Epilepsy. She was/is also team member of other research projects (N2BD, Mitoboost, Tryp-to-Brain, NasalStep, ImpulseN2BD). She has a Scopus h-index of 21 and 1657 citations with 57 published articles in international journals. In addition, she is co-inventor of two international patents. She was Invited Guest Editor of a Special Issue in Pharmaceutics and has been a regular reviewer of publications from Nature, Elsevier, Frontiers, MDPI and others. She received a Research Initiation Grant and a FCT individual PhD Fellow, and 14 awards, among which are the Innovation Award Norberto Pires 2023 and the Acelera@UC Award 2025. In 2024, she was awarded a Sandander Scholarship grant for the Innovation in Teaching course by Harvard Business Education. She also has certification as Investigator-Coordinator in Animal Sciences (EU Functions A+B+D) by FELASA. She supervised 2 PhD students and is currently supervising 2 FCT-funded PhD students. She has collaborations with the pharmaceutical and biotechnology industries (e.g., BIAL, TargTex SA) and health institutions (Coimbra Hospital and University Centre, CHUC.EPE). From an international perspective she has acquired international training and collaborates with research teams from the University of Barcelona (Spain), Federal University of São Paulo (Brazil) and University of Warwick (UK). Her research interests include the blood-brain barrier (BBB) and CNS disorders, namely epilepsy. She has experience in vitro/in vivo pharmacokinetic (ADME) and pharmacodynamic assays applied to drug screening of molecules directed at CNS disorders, as well as therapeutic drug monitoring (personalized medicine), intranasal administration, and development/validation of bioanalytical techniques.
Publications (57)
Targeting NRF2 With Isoeugenol: A Promising Small Molecule for Neurodegenerative, Metabolic, and Chronic Inflammatory Disorders
Oxidative Medicine and Cellular Longevity
2025 | journal-article
Chronopharmacokinetics of the antidepressant paroxetine: An in vitro and in vivo approach
Neuropharmacology
2025 | journal-article
Protective effects of irbesartan against neurodegeneration in APP/PS1 mice: Unraveling its triple anti-apoptotic, anti-inflammatory and anti-oxidant action
Biomedicine & Pharmacotherapy
2025 | journal-article
Novel mechanisms underlying rapid-acting antidepressants: ketamine-like compounds, neurosteroid GABAkines, and psychedelics
Drug Discovery Today
2025 | journal-article
A new population pharmacokinetic model for dosing optimization of zonisamide in patients with refractory epilepsy
European Journal of Pharmaceutical Sciences
2025 | journal-article
New low-dose curcumin derivative with therapeutic potential in Alzheimer’s disease: Results from an in vitro and in vivo study in mice
Neurobiology of Aging
2025 | journal-article
Pharmacokinetics of Non-Psychotropic Phytocannabinoids
Pharmaceutics
2025 | journal-article
Population pharmacokinetics of levetiracetam in patients diagnosed with refractory epilepsy: A real‐world study
Epilepsia
2025 | journal-article
Effect of bioactive extracts from Eucalyptus globulus leaves in experimental models of Alzheimer’s disease
Biomedicine & Pharmacotherapy
2024 | journal-article
Unveiling the potential of intranasal delivery of renin-angiotensin system drugs: Insights on the pharmacokinetics of irbesartan
Biochemical Pharmacology
2024 | journal-article
Synthesis of a dehydrodieugenol B derivative as a lead compound for visceral leishmaniasis—mechanism of action and in vivo pharmacokinetic studies
Antimicrobial Agents and Chemotherapy
2024 | journal-article
Aging and cognitive resilience: Molecular mechanisms as new potential therapeutic targets
Drug Discovery Today
2024 | journal-article
Blood brain barrier dysfunction in healthy aging and dementia: Why, how, what for?
Ageing Research Reviews
2024 | journal-article
Development and validation of an HPLC-DAD method for the quantification of cannabigerol, cannabidiol, cannabinol and cannabichromene in human plasma and mouse matrices
The Analyst
2024 | journal-article
Restoring the epigenome in Alzheimer's disease: advancing HDAC inhibitors as therapeutic agents
Drug Discovery Today
2024 | journal-article
Intranasal delivery of paroxetine: A preclinical study on pharmacokinetics, depressive-like behaviour, and neurochemical sex differences
Biochemical Pharmacology
2024 | journal-article
Krüppel-like factors: potential roles in blood-brain barrier dysfunction and epileptogenesis
Acta Pharmacologica Sinica
2024 | journal-article
Intranasal administration of sertraline ensures sustained brain delivery and antidepressant effect in a mouse model of depression
European Journal of Pharmaceutics and Biopharmaceutics
2024 | journal-article
Targeting Alzheimer's disease hallmarks with the Nrf2 activator Isoeugenol
2023 | preprint
Licochalcone A: A Potential Multitarget Drug for Alzheimer’s Disease Treatment
International Journal of Molecular Sciences
2023 | journal-article
Amorphous nasal powder advanced performance: in vitro/ex vivo studies and correlation with in vivo pharmacokinetics
Journal of Pharmaceutical Investigation
2023 | journal-article
Nasal-PAMPA: A novel non-cell-based high throughput screening assay for prediction of nasal drug permeability
International Journal of Pharmaceutics
2023 | journal-article
Population Pharmacokinetic Analysis of Perampanel in Portuguese Patients Diagnosed with Refractory Epilepsy
Pharmaceutics
2023 | journal-article
Air-liquid interface (ALI) impact on different respiratory cell cultures
European Journal of Pharmaceutics and Biopharmaceutics
2023 | journal-article
Therapeutic Drug Monitoring of Amikacin in Neutropenic Oncology Patients
Antibiotics
2023 | journal-article
Clinical Application of Pharmacokinetics to Appraise Adherence to Levetiracetam in Portuguese Epileptic Patients
Biomedicines
2022 | journal-article
Encapsulated Escitalopram and Paroxetine Intranasal Co-Administration: In Vitro/In Vivo Evaluation
Frontiers in Pharmacology
2021 | journal-article
Antidepressants and Circadian Rhythm: Exploring Their Bidirectional Interaction for the Treatment of Depression
Pharmaceutics
2021 | journal-article
Pharmacology of lacosamide: From its molecular mechanisms and pharmacokinetics to future therapeutic applications.
Life sciences
2021 | journal-article
HPLC method for the determination of antiepileptic drugs in human saliva and its application in therapeutic drug monitoring.
Journal of pharmaceutical and biomedical analysis
2021 | journal-article
Is intranasal administration an opportunity for direct brain delivery of lacosamide?
European Journal of Pharmaceutical Sciences
2021 | journal-article
A combo-strategy to improve brain delivery of antiepileptic drugs: Focus on BCRP and intranasal administration
International Journal of Pharmaceutics
2021 | journal-article
Development and application of an HPLC-DAD technique for human plasma concentration monitoring of perampanel and lamotrigine in drug-resistant epileptic patients
Journal of Chromatography B
2021 | journal-article
Novel Routes to Accessing the Brain: Intranasal Administration
Nanoparticles for Brain Drug Delivery
2020 | book-chapter
Understanding Brain Delivery
Nanoparticles for Brain Drug Delivery
2020 | book-chapter
Cystic fibrosis: Physiopathology and the latest pharmacological treatments
Pharmacological Research
2020 | journal-article
Repairing blood-CNS barriers: Future therapeutic approaches for neuropsychiatric disorders
Pharmacological Research
2020 | journal-article
Pharmacokinetic Monitoring of Levetiracetam in Portuguese Refractory Epileptic Patients: Effect of Gender, Weight and Concomitant Therapy
Pharmaceutics
2020 | journal-article
QbD-driven development of intranasal lipid nanoparticles for depression treatment
European Journal of Pharmaceutics and Biopharmaceutics
2020 | journal-article
Pre-Clinical Assessment of the Nose-to-Brain Delivery of Zonisamide After Intranasal Administration
Pharmaceutical Research
2020 | journal-article
Timing in drug absorption and disposition: the past, present and future of chronopharmacokinetics
British Journal of Pharmacology
2020 | journal-article
Nose-to-brain delivery of natural compounds for the treatment of central nervous system disorders
Current Pharmaceutical Design
2020 | journal-article
Anti-PD-1 immunotherapy in advanced metastatic melanoma: State of the art and future challenges
Life Sciences
2020 | journal-article
Development, validation and application of a new HPLC-DAD method for simultaneous quantification of apixaban, dabigatran, edoxaban and rivaroxaban in human plasma
Journal of Pharmaceutical and Biomedical Analysis
2020 | journal-article
Antidepressants and nose-to-brain delivery: drivers, restraints, opportunities and challenges
Drug Discovery Today
2019 | journal-article
ABC transporters in Drug-resistant Epilepsy: Mechanisms of upregulation and therapeutic approaches
Pharmacological Research
2019 | journal-article
Liquid chromatographic methods for the determination of direct oral anticoagulant drugs in biological samples: A critical review
Analytica Chimica Acta
2019 | journal-article
Nose-to-brain delivery of levetiracetam after intranasal administration to mice
International Journal of Pharmaceutics
2019 | journal-article
Relevance of Breast Cancer Resistance Protein to Brain Distribution and Central Acting Drugs: A Pharmacokinetic Perspective
Current Drug Metabolism
2018 | journal-article
Development and full validation of an innovative HPLC-diode array detection technique to simultaneously quantify lacosamide, levetiracetam and zonisamide in human plasma
Bioanalysis
2018 | journal-article
In vitro assessment of the interactions of dopamine β-hydroxylase inhibitors with human P-glycoprotein and Breast Cancer Resistance Protein
European Journal of Pharmaceutical Sciences
2018 | journal-article
Elucidation of the impact of P-glycoprotein and breast cancer resistance protein on the brain distribution of catechol-O-methyltransferase inhibitors
Drug Metabolism and Disposition
2017 | journal-article
Screening of pharmacokinetic properties of fifty dihydropyrimidin(thi)one derivatives using a combo of in vitro and in silico assays
European Journal of Pharmaceutical Sciences
2017 | journal-article
A new PAMPA model using an in-house brain lipid extract for screening the blood-brain barrier permeability of drug candidates
International Journal of Pharmaceutics
2016 | journal-article
Blood-brain barrier models and their relevance for a successful development of CNS drug delivery systems: A review
European Journal of Pharmaceutics and Biopharmaceutics
2014 | journal-article
Liquid chromatographic methods for the quantification of catecholamines and their metabolites in several biological samples - A review
Analytica Chimica Acta
2013 | journal-article
A chiral HPLC-UV method for the quantification of dibenz[b,f]azepine-5- carboxamide derivatives in mouse plasma and brain tissue: Eslicarbazepine acetate, carbamazepine and main metabolites
Journal of Separation Science
2011 | journal-article
Targeting NRF2 With Isoeugenol: A Promising Small Molecule for Neurodegenerative, Metabolic, and Chronic Inflammatory Disorders
Oxidative Medicine and Cellular Longevity
2025 | journal-article
Chronopharmacokinetics of the antidepressant paroxetine: An in vitro and in vivo approach
Neuropharmacology
2025 | journal-article
Protective effects of irbesartan against neurodegeneration in APP/PS1 mice: Unraveling its triple anti-apoptotic, anti-inflammatory and anti-oxidant action
Biomedicine & Pharmacotherapy
2025 | journal-article
Novel mechanisms underlying rapid-acting antidepressants: ketamine-like compounds, neurosteroid GABAkines, and psychedelics
Drug Discovery Today
2025 | journal-article
A new population pharmacokinetic model for dosing optimization of zonisamide in patients with refractory epilepsy
European Journal of Pharmaceutical Sciences
2025 | journal-article
New low-dose curcumin derivative with therapeutic potential in Alzheimer’s disease: Results from an in vitro and in vivo study in mice
Neurobiology of Aging
2025 | journal-article
Pharmacokinetics of Non-Psychotropic Phytocannabinoids
Pharmaceutics
2025 | journal-article
Population pharmacokinetics of levetiracetam in patients diagnosed with refractory epilepsy: A real‐world study
Epilepsia
2025 | journal-article
Effect of bioactive extracts from Eucalyptus globulus leaves in experimental models of Alzheimer’s disease
Biomedicine & Pharmacotherapy
2024 | journal-article
Unveiling the potential of intranasal delivery of renin-angiotensin system drugs: Insights on the pharmacokinetics of irbesartan
Biochemical Pharmacology
2024 | journal-article
Synthesis of a dehydrodieugenol B derivative as a lead compound for visceral leishmaniasis—mechanism of action and in vivo pharmacokinetic studies
Antimicrobial Agents and Chemotherapy
2024 | journal-article
Aging and cognitive resilience: Molecular mechanisms as new potential therapeutic targets
Drug Discovery Today
2024 | journal-article
Blood brain barrier dysfunction in healthy aging and dementia: Why, how, what for?
Ageing Research Reviews
2024 | journal-article
Development and validation of an HPLC-DAD method for the quantification of cannabigerol, cannabidiol, cannabinol and cannabichromene in human plasma and mouse matrices
The Analyst
2024 | journal-article
Restoring the epigenome in Alzheimer's disease: advancing HDAC inhibitors as therapeutic agents
Drug Discovery Today
2024 | journal-article
Intranasal delivery of paroxetine: A preclinical study on pharmacokinetics, depressive-like behaviour, and neurochemical sex differences
Biochemical Pharmacology
2024 | journal-article
Krüppel-like factors: potential roles in blood-brain barrier dysfunction and epileptogenesis
Acta Pharmacologica Sinica
2024 | journal-article
Intranasal administration of sertraline ensures sustained brain delivery and antidepressant effect in a mouse model of depression
European Journal of Pharmaceutics and Biopharmaceutics
2024 | journal-article
Targeting Alzheimer's disease hallmarks with the Nrf2 activator Isoeugenol
2023 | preprint
Licochalcone A: A Potential Multitarget Drug for Alzheimer’s Disease Treatment
International Journal of Molecular Sciences
2023 | journal-article
Amorphous nasal powder advanced performance: in vitro/ex vivo studies and correlation with in vivo pharmacokinetics
Journal of Pharmaceutical Investigation
2023 | journal-article
Nasal-PAMPA: A novel non-cell-based high throughput screening assay for prediction of nasal drug permeability
International Journal of Pharmaceutics
2023 | journal-article
Population Pharmacokinetic Analysis of Perampanel in Portuguese Patients Diagnosed with Refractory Epilepsy
Pharmaceutics
2023 | journal-article
Air-liquid interface (ALI) impact on different respiratory cell cultures
European Journal of Pharmaceutics and Biopharmaceutics
2023 | journal-article
Therapeutic Drug Monitoring of Amikacin in Neutropenic Oncology Patients
Antibiotics
2023 | journal-article
Clinical Application of Pharmacokinetics to Appraise Adherence to Levetiracetam in Portuguese Epileptic Patients
Biomedicines
2022 | journal-article
Encapsulated Escitalopram and Paroxetine Intranasal Co-Administration: In Vitro/In Vivo Evaluation
Frontiers in Pharmacology
2021 | journal-article
Antidepressants and Circadian Rhythm: Exploring Their Bidirectional Interaction for the Treatment of Depression
Pharmaceutics
2021 | journal-article
Pharmacology of lacosamide: From its molecular mechanisms and pharmacokinetics to future therapeutic applications.
Life sciences
2021 | journal-article
HPLC method for the determination of antiepileptic drugs in human saliva and its application in therapeutic drug monitoring.
Journal of pharmaceutical and biomedical analysis
2021 | journal-article
Is intranasal administration an opportunity for direct brain delivery of lacosamide?
European Journal of Pharmaceutical Sciences
2021 | journal-article
A combo-strategy to improve brain delivery of antiepileptic drugs: Focus on BCRP and intranasal administration
International Journal of Pharmaceutics
2021 | journal-article
Development and application of an HPLC-DAD technique for human plasma concentration monitoring of perampanel and lamotrigine in drug-resistant epileptic patients
Journal of Chromatography B
2021 | journal-article
Novel Routes to Accessing the Brain: Intranasal Administration
Nanoparticles for Brain Drug Delivery
2020 | book-chapter
Understanding Brain Delivery
Nanoparticles for Brain Drug Delivery
2020 | book-chapter
Cystic fibrosis: Physiopathology and the latest pharmacological treatments
Pharmacological Research
2020 | journal-article
Repairing blood-CNS barriers: Future therapeutic approaches for neuropsychiatric disorders
Pharmacological Research
2020 | journal-article
Pharmacokinetic Monitoring of Levetiracetam in Portuguese Refractory Epileptic Patients: Effect of Gender, Weight and Concomitant Therapy
Pharmaceutics
2020 | journal-article
QbD-driven development of intranasal lipid nanoparticles for depression treatment
European Journal of Pharmaceutics and Biopharmaceutics
2020 | journal-article
Pre-Clinical Assessment of the Nose-to-Brain Delivery of Zonisamide After Intranasal Administration
Pharmaceutical Research
2020 | journal-article
Timing in drug absorption and disposition: the past, present and future of chronopharmacokinetics
British Journal of Pharmacology
2020 | journal-article
Nose-to-brain delivery of natural compounds for the treatment of central nervous system disorders
Current Pharmaceutical Design
2020 | journal-article
Anti-PD-1 immunotherapy in advanced metastatic melanoma: State of the art and future challenges
Life Sciences
2020 | journal-article
Development, validation and application of a new HPLC-DAD method for simultaneous quantification of apixaban, dabigatran, edoxaban and rivaroxaban in human plasma
Journal of Pharmaceutical and Biomedical Analysis
2020 | journal-article
Antidepressants and nose-to-brain delivery: drivers, restraints, opportunities and challenges
Drug Discovery Today
2019 | journal-article
ABC transporters in Drug-resistant Epilepsy: Mechanisms of upregulation and therapeutic approaches
Pharmacological Research
2019 | journal-article
Liquid chromatographic methods for the determination of direct oral anticoagulant drugs in biological samples: A critical review
Analytica Chimica Acta
2019 | journal-article
Nose-to-brain delivery of levetiracetam after intranasal administration to mice
International Journal of Pharmaceutics
2019 | journal-article
Relevance of Breast Cancer Resistance Protein to Brain Distribution and Central Acting Drugs: A Pharmacokinetic Perspective
Current Drug Metabolism
2018 | journal-article
Development and full validation of an innovative HPLC-diode array detection technique to simultaneously quantify lacosamide, levetiracetam and zonisamide in human plasma
Bioanalysis
2018 | journal-article
In vitro assessment of the interactions of dopamine β-hydroxylase inhibitors with human P-glycoprotein and Breast Cancer Resistance Protein
European Journal of Pharmaceutical Sciences
2018 | journal-article
Elucidation of the impact of P-glycoprotein and breast cancer resistance protein on the brain distribution of catechol-O-methyltransferase inhibitors
Drug Metabolism and Disposition
2017 | journal-article
Screening of pharmacokinetic properties of fifty dihydropyrimidin(thi)one derivatives using a combo of in vitro and in silico assays
European Journal of Pharmaceutical Sciences
2017 | journal-article
A new PAMPA model using an in-house brain lipid extract for screening the blood-brain barrier permeability of drug candidates
International Journal of Pharmaceutics
2016 | journal-article
Blood-brain barrier models and their relevance for a successful development of CNS drug delivery systems: A review
European Journal of Pharmaceutics and Biopharmaceutics
2014 | journal-article
Liquid chromatographic methods for the quantification of catecholamines and their metabolites in several biological samples - A review
Analytica Chimica Acta
2013 | journal-article
A chiral HPLC-UV method for the quantification of dibenz[b,f]azepine-5- carboxamide derivatives in mouse plasma and brain tissue: Eslicarbazepine acetate, carbamazepine and main metabolites
Journal of Separation Science
2011 | journal-article




